The peak of venture investment for digital health was in 2020 and 2021, precipitously declining later in 2022. And the outlook for 2023 is practical and Show-Me: that is, demonstrate clinical outcomes and return-on-investment before “I” (for investors) can take a leap of faith to spend a dollar, a Yen, a Euro, or British pound on a shiny new-new healthcare thing.
If it’s January, then CES and JP Morgan convene their influential annual meetings which feature health technology for globally engaged health industry stakeholders — investors, surely, but also providers, innovators, analysts, and insurers.
In my January 2023 column for Medecision. I weave the pragmatic story together based on datapoints from JP Morgan’s 2023 annual healthcare meeting in San Francisco and CES 2023 held in Las Vegas the previous week.
Check out the full plotline here on the Medecision blog portal.
It was an honor to be 
January 2027 is in our sights, and that means we're making plans for #CES2027. I've attended the largest consumer electronics show for nearly 20 years, tracking the evolution of digital health which enables people for greater self-care and health agency and literacy. I'm looking forward to collaborating on this webcast with fellow CES experts in their fields to brainstorm what we expect in this 
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance.